Devin Whittemore Smith's Net Worth
$12.6 Thousand
Who is Devin Whittemore Smith?
Devin Whittemore Smith does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include YUMANITY THERAPEUTICS, INC., Minerva Neurosciences, Inc., and IO Biotech, Inc..
SEC CIK
Devin Whittemore Smith's CIK is 0001747818
Past Insider Trading and Trends
2023 was Devin Whittemore Smith's most active year for acquiring shares with 3 total transactions. Devin Whittemore Smith's most active month to acquire stocks was the month of July. 2022 was Devin Whittemore Smith's most active year for disposing of shares, totalling 2 transactions. Devin Whittemore Smith's most active month to dispose stocks was the month of May. 2023 saw Devin Whittemore Smith paying a total of $9,999.45 for 159,876 shares, this is the most they've acquired in one year. In 2022 Devin Whittemore Smith cashed out on 6,039 shares for a total of $8,760.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
YUMANITY THERAPEUTICS, INC. (KA) Snapshot price: $0.65
SVP and General CounselDevin Whittemore Smith owns 13,961 units of Common Stock which is worth $9,074.65. In the year 2021 Devin Whittemore Smith filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.25% | -3.12K |
$1.69 | -$5,269.16 | 13.96K |
Dec 2
| |||
Form 4
| -14.62% | -2.92K |
$1.19 | -$3,491.82 | 17.08K |
Jun 3
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Minerva Neurosciences, Inc. (NERV) Snapshot price: $2.65
SVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $0.843
General CounselDevin Whittemore Smith owns 4,938 units of Common Stock which is worth $4,162.73. In the year 2023 Devin Whittemore Smith acquired a total of 4,938 shares in IO Biotech, Inc. at a cost of $9,382.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
∞
| 4.94K |
$1.90 | $9,382.20 | 4.94K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||